Medications with Generic Name Beginning ‘V’

Page 1 of 104 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

CNJ-016 (Vaccinia Immune Globulin (Human))

VIGIV (vaccinia immune globulin intravenous, human) is indicated for the treatment and/or modification of the following conditions: Eczema vaccinatum. Progressive vaccinia. …

Emergent BioSolutions Canada Inc.17 May 2019

Valacyclovir

1.1 Adult Patients Cold Sores (Herpes Labialis): Valacyclovir Tablets USP are indicated for treatment of cold sores (herpes labialis). The efficacy of valacyclovir hydrochloride initiated after the development of clinical signs of a cold sore (e.g…

Direct Rx22 June 2016

VALACYCLOVIR

1.1 Adult Patients Cold Sores (Herpes Labialis): Valacyclovir tablets USP are indicated for treatment of cold sores (herpes labialis). The efficacy of valacyclovir tablets USP initiated…

DirectRX24 April 2019

Valacyclovir

Valacyclovir tablet USP is a nucleoside analogue DNA polymerase inhibitor indicated for: Adult Patients (1.1) Cold Sores (Herpes Labialis) Genital Herpes Treatment in…

Unit Dose Services20 August 2019

Valacyclovir

Valacyclovir tablet USP is a nucleoside analogue DNA polymerase inhibitor indicated for: Adult Patients (1.1) Cold Sores (Herpes Labialis) Genital Herpes Treatment in…

Bryant Ranch Prepack11 September 2019

Page 1 of 104 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

Hospira Issues A Voluntary Nationwide Recall for One Lot of Sterile Water for Injection, USP, Due to the Potential Presence of Visible Particulate
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot DN9185 of Sterile Water for Injection, USP, 100 mL Single Dose Glass Fliptop Vial, to the hospital/institution level due to a confirmed customer report for a single vial with a visible…
Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection, USP and One Lot of 1% Lidocaine HCl Injection, USP Due to Mislabeling
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot EG6023 of 0.5% Bupivacaine Hydrochloride Injection, USP 30 mL and lot EG8933 of 1% Lidocaine HCl Injection, USP 30 mL, to the hospital/institution level due to mislabeling whereby a…

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.